Volume 8, Issue 6, Pages (June 2017)

Slides:



Advertisements
Similar presentations
Volume 5, Issue 5, Pages (November 2015)
Advertisements

Figure 5 ISOX and vorinostat partially restore splicing pattern in DM1 patient-derived fibroblasts. (A) ISOX and vorinostat partially rescue mis-splicing.
Volume 8, Issue 3, Pages (March 2017)
Volume 3, Issue 6, Pages (December 2014)
Volume 9, Issue 1, Pages (July 2017)
Volume 5, Issue 1, Pages (July 2015)
Volume 9, Issue 5, Pages (November 2017)
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Jurian Schuijers, Laurens G. van der Flier, Johan van Es, Hans Clevers 
Volume 3, Issue 1, Pages (July 2014)
Volume 9, Issue 2, Pages (August 2017)
Volume 13, Issue 2, Pages (August 2013)
Volume 4, Issue 4, Pages (April 2015)
Volume 8, Issue 6, Pages (June 2017)
Volume 1, Issue 5, Pages (November 2013)
Volume 29, Issue 1, Pages (April 2014)
CaMKII inhibition in human primary and pluripotent stem cell-derived chondrocytes modulates effects of TGFβ and BMP through SMAD signaling  B. Saitta,
Volume 10, Issue 5, Pages (May 2018)
Fuqing Wu, David J. Menn, Xiao Wang  Chemistry & Biology 
Promoting Myelin Repair through In Vivo Neuroblast Reprogramming
Volume 7, Issue 3, Pages (September 2016)
Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells  Yangling Li, Miao Xian, Bo Yang, Meidan.
Volume 5, Issue 5, Pages (November 2015)
Volume 5, Issue 5, Pages (November 2015)
Volume 36, Issue 2, Pages (January 2016)
Volume 8, Issue 3, Pages (March 2017)
Volume 7, Issue 3, Pages (September 2016)
Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts
Volume 23, Issue 5, Pages (November 2012)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 16, Issue 3, Pages (March 2015)
Volume 7, Issue 1, Pages 1-10 (July 2016)
Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells
Volume 8, Issue 2, Pages (February 2017)
Volume 6, Issue 5, Pages (May 2016)
Derivation and FACS-Mediated Purification of PAX3+/PAX7+ Skeletal Muscle Precursors from Human Pluripotent Stem Cells  Bianca Borchin, Joseph Chen, Tiziano.
Volume 1, Issue 6, Pages (December 2013)
Volume 9, Issue 5, Pages (November 2017)
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
Volume 9, Issue 4, Pages (November 2014)
Volume 6, Issue 6, Pages (June 2016)
Volume 8, Issue 5, Pages (May 2017)
Volume 9, Issue 1, Pages (October 2014)
Volume 25, Issue 7, Pages (July 2017)
Volume 2, Issue 1, Pages (January 2014)
Volume 9, Issue 4, Pages (October 2017)
Volume 5, Issue 2, Pages (August 2015)
Volume 21, Issue 1, Pages (January 2011)
Volume 3, Issue 6, Pages (December 2014)
A Synthetic Niche for Nephron Progenitor Cells
Volume 8, Issue 6, Pages (June 2017)
Volume 5, Issue 5, Pages (November 2015)
Giulia Quattrocolo, Gord Fishell, Timothy J. Petros  Cell Reports 
Increased Expression of Laminin Subunit Alpha 1 Chain by dCas9-VP160
Activin Signals through SMAD2/3 to Increase Photoreceptor Precursor Yield during Embryonic Stem Cell Differentiation  Amy Q. Lu, Evgenya Y. Popova, Colin.
EVA1A/TMEM166 Regulates Embryonic Neurogenesis by Autophagy
Volume 3, Issue 2, Pages (August 2014)
Volume 7, Issue 2, Pages (August 2016)
Volume 26, Issue 6, Pages (June 2018)
Volume 2, Issue 3, Pages (March 2014)
Volume 9, Issue 1, Pages (July 2017)
Efficient gene transfer into the epithelial cell layer of embryonic mouse intestine using low-voltage electroporation  Helen E. Abud, Peter Lock, Joan.
Volume 17, Issue 3, Pages (October 2016)
Giulia Quattrocolo, Gord Fishell, Timothy J. Petros  Cell Reports 
Volume 6, Issue 3, Pages (March 2016)
Volume 10, Issue 6, Pages (June 2018)
Volume 25, Issue 6, Pages (June 2017)
Volume 9, Issue 1, Pages (July 2017)
Volume 5, Issue 6, Pages (December 2015)
Maureen Wanjare, Sravanti Kusuma, Sharon Gerecht  Stem Cell Reports 
Presentation transcript:

Volume 8, Issue 6, Pages 1770-1783 (June 2017) Defined and Scalable Differentiation of Human Oligodendrocyte Precursors from Pluripotent Stem Cells in a 3D Culture System  Gonçalo M.C. Rodrigues, Thomas Gaj, Maroof M. Adil, Joyce Wahba, Antara T. Rao, Franziska K. Lorbeer, Rishi U. Kulkarni, Maria Margarida Diogo, Joaquim M.S. Cabral, Evan W. Miller, Dirk Hockemeyer, David V. Schaffer  Stem Cell Reports  Volume 8, Issue 6, Pages 1770-1783 (June 2017) DOI: 10.1016/j.stemcr.2017.04.027 Copyright © 2017 The Author(s) Terms and Conditions

Stem Cell Reports 2017 8, 1770-1783DOI: (10.1016/j.stemcr.2017.04.027) Copyright © 2017 The Author(s) Terms and Conditions

Figure 1 Generation of an NKX2.2-EGFP hESC Reporter Line (A) Schematic of the gene-targeting strategy used to generate reporter cells. The top cartoon depicts the strategy to optimize early OPC differentiation using CRISPR/Cas9 genome engineering, and the bottom cartoon indicates the structures of the donor plasmid and the nkx2.2 locus before and after gene targeting. Genetic elements are not displayed to scale. (B) Normalized luciferase activity in HEK293T cells co-transfected with a reporter plasmid containing four repeats of the NKX2.2 binding site sequence upstream a luciferase reporter gene along with an expression vector encoding either wild-type (WT) NKX2.2 or NKX2.2-EGFP (four technical replicates per condition). Mean and SD are shown. (C) Southern blot of puromycin-resistant WIBR3 hESCs after electroporation with the SpCas9-sgRNA expression vector and the NKX2.2-EGFP donor plasmid. Genomic DNA was digested with SacI and hybridized with a 32P-labeled EGFP probe (see Figure 1A, bottom scheme) that detects a 3.2-kb fragment present only in gene-targeted clones. (D) Phase-contrast image of N30 cells grown in Mebiol gel for 5 days under expansion conditions. Scale bar, 200 μm. (E) Immunocytochemistry analysis of NKX2.2-EGFP and the pluripotency markers OCT4 and NANOG in N30 cells after expansion in the synthetic hydrogel. Scale bar, 50 μm. (F) Western blot of cell lysate from N30 cells after differentiation for 20 days using multiple different conditions. Despite the presence of EGFP in the N30 hESC sample lane, no EGFP fluorescence was observed in N30 cells by fluorescence microscopy or flow cytometry. Stem Cell Reports 2017 8, 1770-1783DOI: (10.1016/j.stemcr.2017.04.027) Copyright © 2017 The Author(s) Terms and Conditions

Figure 2 Optimization of Early OPC Differentiation in 3D (A) Conditions used for early OPC differentiation. The left diagram indicates the different stages of development of early OPCs and the markers expressed during those stages. The right scheme depicts the different combinations of factors used for differentiation. The best performing condition (6) is highlighted with a black arrow. (B) Analysis of NKX2.2-EGFP fluorescence after N30 cells were differentiated for 18 days in 3D using conditions 3 and 6. (C) Heatmap illustrating NKX2.2-EGFP mean fluorescence intensity (MFI) after N30 cells were differentiated for 10, 14, 18, or 20 days using conditions 1–7 (three technical replicates per condition). (D–F) ICC analysis after N30 cells were differentiated for 18 days in 3D using condition 6 (D and F) and condition 3 (E). (G–I) Quantitative analysis of ICC using CellProfiler after N30 cells were differentiated for 14 and 18 days. The percentage of positive cells was normalized to DAPI-stained nuclei (>1,000 cells/condition × 3 independent experiments). Mean and SD are shown. (J) Temporal ClustVis analysis of qPCR gene expression after N30 cells were differentiated in 3D. The concentrations of factors shown in the heatmap caption are: RA (red = 0 nM, blue = 100 nM), SHH (red = 0 ng/mL, blue = 100 ng/mL), SAG (red = 0 μM, white = 0.5 μM, blue = 1 μM), and CHIR (red = 0 μM, blue = 3 μM) (three technical replicates). (K) Temporal fold-expansion analysis of N30 cells differentiated in 2D or 3D for 11 and 20 days, using condition 6. Expansion was normalized to the number of cells seeded for differentiation (four technical replicates per condition × 4 independent experiments). ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001 by Mann-Whitney test. Scale bars, 50 μm (B, D, and F) and 100 μm (E). Stem Cell Reports 2017 8, 1770-1783DOI: (10.1016/j.stemcr.2017.04.027) Copyright © 2017 The Author(s) Terms and Conditions

Figure 3 Early OPC Differentiation in hPSCs (A) Temporal ClustVis analysis of qPCR gene expression after H9 hESCs were differentiated in 3D (three technical replicates). (B and D) ICC analysis of early OPC markers and the proliferation marker Ki-67 after H9 (B) and TCTF (D) cells were differentiated in 3D for 18 days. Scale bars, 50 μm. (C and E) Quantitative analysis of ICC using CellProfiler after H9 (C) and TCTF (E) cells were differentiated for 14 and 18 days (>1,000 cells × 3 independent experiments). Mean and SD are shown. (F) Temporal qPCR analysis of early OPC gene expression after TCTFs were differentiated for 12 and 16 days in 3D (three technical replicates). Stem Cell Reports 2017 8, 1770-1783DOI: (10.1016/j.stemcr.2017.04.027) Copyright © 2017 The Author(s) Terms and Conditions

Figure 4 3D Differentiation Enables Oligodendrocyte Maturation (A) Conditions tested for OPC maturation. The left diagram illustrates different developmental stages for OPCs and oligodendrocytes and lists their specific markers. The right scheme depicts the strategies used for oligodendrocyte maturation after the differentiation of early OPCs with condition 6. Early FGF, the best performing method, is highlighted with a black arrow. (B) Quantification of O4 expression by ICC after differentiating H9 cells for 95 days using several different strategies and passaging cells onto 2D on day 75. Results show the average number of O4+ cells (per initial 1,000 hPSCs seeded for differentiation) present in each of the IXM-imaged culture areas. Cells were counted using CellProfiler software (25 fields per condition, with >200 cells each, × 4 independent experiments). (C) ICC analysis of H9 cells differentiated for 18 days using early FGF. (D and E) ICC analysis of H9 cells differentiated for 55 and 65 days using early FGF. (F) qPCR analysis of OPC and oligodendrocyte gene expression in H9 cells differentiated for 50, 75, and 95 days (three technical replicates). (G and I) ICC analysis of H9 cells differentiated for 89 and 95 days using early FGF and passed onto 2D after 75 days of differentiation in 3D. (H) Quantification of O4 expression analysis by ICC using CellProfiler after N30 cells were differentiated for 95 days using the seven different conditions tested for early OPC differentiation in 3D. Results show the average number of O4+ cells differentiated per initial 1,000 hPSCs seeded for differentiation. Cells were passed onto 2D on day 75 (>1,000 cells/condition × ≥3 independent experiments). Mean and SD are shown. ∗p < 0.05 by Mann-Whitney test. Scale bars, 50 μm (C and D [left and right], E and G [left], and I), 20 μm (D [middle] and G [right]), and 100 μm (G, middle). Stem Cell Reports 2017 8, 1770-1783DOI: (10.1016/j.stemcr.2017.04.027) Copyright © 2017 The Author(s) Terms and Conditions

Figure 5 3D Differentiation Generates Firing and Non-firing OPCs (A) Multicolor epifluorescence imaging of voltage-sensitive dye fluorescence localized to the cell membrane of live-stained O4+ OPCs. Cells were differentiated for 89 days using condition 6 with early FGF treatment and passed onto 2D on day 75 for imaging. Scale bars, 20 μm. (B) Optical recording of membrane potential in firing (1 and 2) and non-firing OPCs (3 and 4) after field stimulation using a 1-ms pulse from a transwell stimulation electrode. Stem Cell Reports 2017 8, 1770-1783DOI: (10.1016/j.stemcr.2017.04.027) Copyright © 2017 The Author(s) Terms and Conditions

Figure 6 OPCs Generated in 3D Engraft, Migrate, and Mature In Vivo (A) Schematic illustration of the injection site in the corpus callosum of NOD/SCID mice. H9 cells were differentiated for 50 days in 3D using condition 6 with early FGF treatment and transplanted as cell-spheres into 30-day-old mice. (B–D) Immunohistochemistry analysis for the expression of human nuclear antigen (HNA) with (B) OLIG2, (C) NG2, (D) SOX10, and PDGFR in brain tissue sections from NOD/SCID at 3 weeks after transplantation. White arrow indicates transplanted-OPC migration into the corpus callosum. (E–I) IHC analysis of brain tissue sections from NOD/SCID at 4 and 6 months after transplantation. (E) Stitched image of a coronal section showing HNA+ cell migration into the corpus callosum and across the cortex, away from the injection site. The posterior forceps of the corpus callosum are indicated by the yellow dashed line. HNA and GFAP images, which were taken from the hemisphere where cells were implanted, are shown at a higher magnification. (G) Quantification of the HNA+ cells that survived implantation at 3 weeks, 4 months, and 6 months after transplantation, normalized to the number of cells injected (150,000 cells). Each dot represents the average number of cells estimated per animal (≥6 sections per animal, sampling the entire range where HNA+ cells were found, were analyzed). Mean and SD are shown. (F and H) IHC of HNA+ cells that co-express OLIG2, SOX10, and MBP. Orange arrows indicate HNA+/OLIG2+ cells, red arrow indicates an HNA+ cell, green arrow indicates one mouse OLIG2+ cell, and the white arrow indicates one HNA+/SOX10+/MBP+ cell. (I) Confocal z stacks of HNA+ cells that co-express MBP and SOX10. Scale bars, 250 μm (E), 200 μm (B, left), 100 μm (F and H), 50 μm (B [right], C, and D), and 10 μm (I). Stem Cell Reports 2017 8, 1770-1783DOI: (10.1016/j.stemcr.2017.04.027) Copyright © 2017 The Author(s) Terms and Conditions